Capstone Wealth Management Group (Pennsylvania)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Capstone Wealth Management Group (Pennsylvania)'s ABBV Position: Q2 2026 in Review
Capstone Wealth Management Group (Pennsylvania) increased its AbbVie (ABBV) stake by 1.6% in Q2 2026, buying an estimated $8.39K and bringing the position to 2,545 shares worth $640K. The position accounts for 0.23% of the portfolio, ranked #53.
Capstone Wealth Management Group (Pennsylvania) first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $694K in Q3 2024. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Capstone Wealth Management Group (Pennsylvania) held 2,545 shares of AbbVie worth $640K as of Q2 2026.
- Capstone Wealth Management Group (Pennsylvania) bought 39 AbbVie shares in Q2 2026, an estimated $8.39K.
- AbbVie made up 0.23% of Capstone Wealth Management Group (Pennsylvania)'s portfolio in Q2 2026, its #53 holding.
- Capstone Wealth Management Group (Pennsylvania) first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- Capstone Wealth Management Group (Pennsylvania)'s AbbVie position peaked at $694K in Q3 2024.
- 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Capstone Wealth Management Group (Pennsylvania)'s 13F filing for Q2 2026, filed 30 Jul 2026.